Efficacy Study of Dextromethorphan to Treat Rheumatoid Arthritis
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Rheumatoid arthritis were randomized to a 6-month treatment of oral dextromethorphan
hydrobromide or placebo as an add-on therapy to traditional disease-modifying anti-rheumatic
drugs (DMARDs). Disease activity were assessed.